Sarcoma, Ewing

16 registered clinical trials studyying Sarcoma, Ewing — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982	Essen Biotech	Phase 1 / Phase 2
Recruiting	Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomi NCT06709495	David S Shulman, MD	Phase 1 / Phase 2
Suspended	Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Ref NCT04890093	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma NCT05046314	Shanghai Pharmaceuticals Holding Co., Ltd	Phase 2
Recruiting	A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning NCT06387485	Ricoh USA, Inc.	N/A
Completed	Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery NCT05772312	Istituto Ortopedico Rizzoli	—
Active Not Recruiting	CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma NCT05440786	Eli Lilly and Company	Phase 2
Completed	The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma NCT05100368	Istituto Ortopedico Rizzoli	—
Active Not Recruiting	SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma NCT03778996	Sarcoma Oncology Research Center, LLC	Phase 2
Terminated	A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomi NCT03495921	Gradalis, Inc.	Phase 3
Completed	Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Ro NCT03275818	Grupo Espanol de Investigacion en Sarcomas	Phase 2
Terminated	Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms T NCT02581384	Dana-Farber Cancer Institute	Phase 1 / Phase 2
Withdrawn	HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Soli NCT02557854	Theodore Laetsch	Phase 1
Terminated	TK216 in Patients With Relapsed or Refractory Ewing Sarcoma NCT02657005	Oncternal Therapeutics, Inc	Phase 1 / Phase 2
Completed	Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sar NCT02415816	St. Jude Children's Research Hospital	N/A
Completed	Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors NCT01661400	Washington University School of Medicine	Phase 1